Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Array BioPharma
Array BioPharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Research & Development
Array BioPharma closes cancer drug deal with Pierre Fabre
Array may receive up to US$425m in agreement to develop novel oncology products
Manufacturing
Accuratus expands capabilities with acquisition of CMC operations of Array Biopharma
The Array CMC operation will be known as Avista Pharma Solutions and housed in a state-of-the-art, laboratory facility in Longmont, Colorado
Regulatory
Anticancer agent – binimetinib
The new generation of genetically targeted anticancer agents is being developed for melanoma patients with specific mutations
Pharmaceutical
Array BioPharma appoints Victor Sandor as Chief Medical Officer
Clinical oncology expert joins as the company advances its late-stage clinical programmes
Pharmaceutical
Andrew Robbins joins Array BioPharma
Takes newly created role of senior vice president of commercial operations
Pharmaceutical
Array BioPharma appoints new ceo
Ron Squarer joins the US biopharmaceutical firm
Pharmaceutical
Array BioPharma names vp of Regulatory Affairs and Quality Assurance
Howard Holden brings 25 years’ experience to the role
Subscribe now